Skip to main content
Clinical and Translational Medicine
Figure 1 | Clinical and Translational Medicine

Figure 1

From: Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression

Figure 1

The significant variations in fatigue in the 3 groups evaluated in Figures 2 and 3 , namely patients at the screening stage (inclusion, all patients), including all 43 patients (32 patients whose fatigue worsened after chemotherapy and 11 patients whose fatigue did not worsen after chemotherapy and who served as controls for this stage of data analysis). The black dots represent the outliers.

Back to article page